Home
TVRD
TVRD News

Latest Tvardi Therapeutics Inc. Common Stock (TVRD) News on June 1, 2025

Oppenheimer Predicts Up to ~550% Jump for These 2 ‘Strong Buy’ Stocks

TipRanks

10 hours ago

Oppenheimer Predicts Up to ~550% Jump for These 2 ‘Strong Buy’ Stocks

Business Wire

5 days ago

Tvardi Therapeutics Announces Completion of Enrollment in Phase 2 Clinical Trial of TTI-101 in Idiopathic Pulmonary Fibrosis

Business Wire

12 days ago

Tvardi Therapeutics to Participate in Upcoming Investor Conferences

Business Wire

19 days ago

Tvardi Therapeutics Announces First Quarter 2025 Results and Provides Business Update

Business Wire

a month ago

Tvardi Therapeutics Announces Presentation at the American Thoracic Society 2025 Annual Conference

Share on Social Networks: